Background and Purpose-Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease.
A merican trypanosomiasis, Chagas disease (CD), is a major public health problem and a major cause of cardiomyopathy in South America. 1 It is an emerging medical problem in the United States. CD is an acute or chronic infection caused by the flagellate protozoan Trypanosoma cruzi (T cruzi), transmitted by bugs of the family Reduviidae, subfamily Triatominae. 2, 3 T cruzi infection is widespread from southern Chile, Argentina, and Brazil, throughout South and Central America, extending to southern Texas. Geographic strain differences result in distinct tissue tropism, virulence, and clinical manifestations. 4 Up to 8% of the population in South America is seropositive, but only 10% to 30% of these will have symptomatic disease. 1 The emigration of several million people from T cruzi-endemic countries to the United States has raised concerns regarding a possible increase in cases of Chagas heart disease, as well as an increased risk of transfusion-transmitted T cruzi. 5, 6 Irreversible damage to the heart can appear 10 to 20 years after chagasic infection. 7 Heart-related diseases in CD includes cardiomegaly, dysrhythmia, heart failure, and sudden cardiac death. 8 Pathologic studies of the brain have shown cerebral infarction in 9.4% and 26.3% 9, 10 of patients with the chronic form of CD. Previous studies described a predominant cardioembolic cause of ischemic stroke in CD. 11, 12 The influence of other vascular risk factors on the appearance of ischemic stroke is not fully defined.
The aim of this study is to: (1) evaluate vascular risk factors of ischemic stroke in CD, compared with a control nonchagasic stroke patients; and (2) analyze the prevalence of a thrombophilic state in patients with stroke caused by CD. Associated vascular risk factors were analyzed to identify the variables that could predict higher risk of stroke in both the chronic and latent forms of CD.
Materials and Methods
All patients consecutively admitted to the Department of Neurology at Sarah hospital, in Brasilia DF, Brazil, during the 18 months from Data were collected on vascular risk factors, location of brain lesion, diagnostic stroke subtype, electrocardiography, and echocardiography findings. Demographic variables included age, sex, previous history of stroke, and vascular risk factors. All chagasic and nonchagasic stroke patients underwent a diagnostic protocol for stroke including ECG, chest radiograph, carotid echo Doppler, transcranial Doppler, bubble test transcranial Doppler, transthoracic and/or transesophageal echocardiogram, and a brain computerized tomography. Brain MRI was used when necessary in 23% patients. Thrombophilia studies were also determined in all case and control subjects. These included fasting plasma levels of protein C, protein S, antithrombin III, levels of homocysteine, activated protein C resistance, IgG anticardiolipin antibodies, and lupus anticoagulant. Genetic tests for the factor V Leiden and the C677T methylene tetrahydrofolate reductase gene mutation were obtained in all subjects. Additional biochemical studies included Veneral Disease Research Laboratory serology and antinuclear antibodies. CD immunofluorescence and hemagglutination tests and study of hemoglobinopathies (sickle cell anemia) were obtained in all subjects. Homocystinemia was diagnosed when the mean of its serum level was Ͼ13 mol/L.
We defined the presence of CD in a stroke patient when both immunofluorescence and hemagglutination were positive. Diagnosis of stroke was confirmed by clinical and/or radiological findings. 13 The Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria 14 was used to define stroke subtype: large-artery atherosclerosis, small-vessel occlusion, cardioembolism, other determined causes and undetermined causes. For the purpose of the study, we considered only ischemic strokes, as defined by TOAST criteria, in patients who had both a positive Chagas serology with suspected latent CD or chronic symptomatic cardiac CD. Patients with cerebral hemorrhage were excluded from the study. Chagasic patients were divided into 2 groups: patients with previous history of symptomatic chagasic cardiomyopathy and patients with chronic asymptomatic forma of CD to establish differences in the prevalence of vascular risk factors in both groups.
The topographical classification of stroke followed the Oxfordshire classification. 15 Total anterior circulation infarctions included large strokes (but not bilateral carotid occlusions) in the anterior circulation territory. Partial anterior circulation infarctions included small strokes (not lacunae) in the same territory. Lacunar syndromes and posterior circulation infarctions were also studied.
Statistical analysis was performed using SPSS. Risk factor comparison for subjects with and without CD was performed using t tests for continuous variables and 2 test and Fisher exact test for categorical variables. A 2-tailed PϽ0.05 was considered statistically significant. Odds ratio (OR) and 95% limit confidence interval (CI) were performed. A forward logistic regression analysis was done for significant variables observed on univariate analysis. 85.1% of CD stroke patients had at least 1 defined vascular risk factor (94% in control group; Pϭ0.021), with the most frequent being hypertension (61.7%), followed by congestive heart failure (27.66%) and hyperlipidemia (19.15%). A past history of stroke was identified in 22.34% of CD stroke patients and 20% of controls.
Results

During
Vascular risk factors in stroke patients showed a significantly higher frequency of hypertension (88% versus 61.70%; Pϭ0.0004) and hypercholesterolemia (19.15% versus 33.33%; Pϭ0.016) in the control group. Whereas congestive heart failure (27.66% versus 2.667%; Pϭ0.000) and atrial fibrillation (13.83 versus 5.33%; Pϭ0.021) were significantly more frequent in the Chagasic stroke group. Table 2 describes the ECG and echocardiogram findings in stroke patients. 67% of CD patients and 23.3% of control group had an abnormal ECG (Pϭ0.000). Ten chagasic patients had previous pacemaker insertion, whereas there was just one nonchagasic stroke patient (Pϭ0.000). All stroke patients underwent an echocardiogram, either transthoracic (58.51% versus 71%) or transthoracic and transesophageal ones (41.49% versus 28.86%). A normal echocardiogram was obtained in only 34% of CD patients. Left ventricular (LV) diastolic dysfunction was the most frequent echocardiography finding in CD stroke patients (48.94% versus 58.667%).
We found an apical aneurysm in 35 CD stroke patients. Table 3 describes characteristics of the strokes experienced by our study population. According to TOAST criteria, we defined 56.38% of CD stroke patients as cardioembolism (with a clear source of embolus), 8.51% as atherothrombotic stroke, 9.57% as small-vessel stroke, and 25.53% as stroke of undetermined cause. In this last group, we included stroke patients with normal carotid Doppler, presence of hypertension, and findings on echocardiograph such as LV dysfunction. Cardioembolism (56.38% versus 9.33%; Pϭ0.000) was significantly more frequent in the CD stroke group, whereas large-artery atherosclerosis (8.51% versus 20%; Pϭ0.031) and small-vessel occlusion (9.57% versus 34.667%; Pϭ0.000) were significantly more frequent in nonchagasic stroke group.
The most frequent stroke syndromes in CD patients and stroke control group were, respectively, partial anterior circulation infarctions (48.94% versus 32%; Pϭ0.008) followed Table 4 shows prevalence of thrombophilia states in chagasic and nonchagasic stroke patients. We did not observe differences in prevalence of thrombophilia states, such as protein C or S deficiency, antithrombin III deficiency, APR resistance, factor V Leyden mutation, lupus anticoagulant, or anticardiolipin antibodies. Sickle cell anemia (6.38% versus 1.33%; Fisher exact test 0.039) was significantly more frequent in CD patients. Hyperhomocystinemia was significantly more frequent in nonchagasic stroke patients (55.33% versus 36.17%; Pϭ0.004). Nonchagasic stroke patients had significantly higher levels of homocysteine (mean homocysteine: 17.43% versus 13.25%; 2-tail Student t 0.000). Distribution of mutation of the gene of the methylene tetrahydrofolate reductase gene mutation was similar in both groups of ACA indicates anterior cerebral artery; LACI, lacunar infarction; MCA, middle cerebral artery; PACI, partial anterior circulation infarction; PCA, posterior cerebral artery; POCI, posterior circulation infarction; TACI, total anterior circulation infarction. stroke patients. Secondary prevention with oral anticoagulants was significantly more prevalent at hospitalization in the group of chagasic stroke patients (30.85 versus 6.66; Pϭ0.000).
In a subanalysis, we placed chagasic patients in 2 groups. Group A consisted of any CD stroke patient with previous symptoms of chagasic cardiopathy, including heart failure, cardiomyopathy, atrial fibrillation, or use of pacemaker; group B consisted of latent CD or chronic CD without clinical symptoms of cardiopathy but included persons with asymptomatic right bundle block. The distribution of the following variables and vascular risk factors was similar in both groups: age, history of previous stroke, diabetes, hypertension, smoking, dyslipidemia, and apical aneurysm. The cardioembolism subtype of stroke predominated in group A, whereas the undetermined etiology and small-vessel occlusion subtypes were significantly more frequent in group B. Prevalence of thrombophilia was similar in both groups.
Significant variables on univariate analysis (stroke age, sex, vascular risk factors, hypertension, smoking, cardiac arrhythmia, dyslipidemia, arrhythmia on ECG, apical aneurysm, mural thrombus, LV dysfunction, dilated cardiomyopathy, cardiac insufficiency) were further analyzed in a stepwise forward logistic regression model. Statistical analysis of prevalence of vascular risk factors and thrombophilia was done within the subgroup of nonhypertensive chagasic patients. In the stepwise regression analysis model, significant variables associated with CD stroke in nonhypertensive CD stroke patients were apical aneurysm, LV dysfunction, dysrhythmia on ECG, and female sex.
Discussion
Chronic cardiomyopathy is the most common clinical form of CD. 16 The apical region of the LV is a critical region in the chagasic heart, where aneurysm, thrombus, or both occur with high frequency. In a retrospective study of 1345 CD autopsy reports, 17 frequency of a cardiac thrombus was 36% in severe heart disease patients and 15% in the cases of sudden death. The frequency of apical aneurysm in CD patients studied by echocardiography have been reported to be in the range of 20% to 35%. 18 A previous report of cerebral embolism and stroke observed a rate of 12.7% of apical lesions of the LV. 19 In our study, prevalence of apical aneurysm in CD stroke patients of 37% is considerably higher than controls and occurred in 44% of nonhypertensive CD stroke patients. A bias selection about prevalence of apical aneurysm in our group of CD stroke patients cannot be ruled out, because this is a hospital study and not a population study CD stroke seems to be lower in patients with mild to moderate heart failure. 20 A survival advantage for women presenting with heart failure has been reported in the Framingham heart study. If this assumption is true as well in CD patients, chagasic women affected by a CD cardiomyopathy might be expected to have a longer survival. Thus, they would also be at greater risk of embolic stroke. This hypothesis may explain the higher frequency of CD stroke that we observed in chagasic women. Other authors have described the same phenomenon. 12,21 Clinical implications derived from this study suggest that South American stroke patients should perform an indirect immunofluorescence test to rule out CD. We did not find a higher frequency of thrombophilia in chagasic patients. Thus, no special attention to thrombophilia studies is recommended in this population. We demonstrated that at least 56.3% of chagasic strokes are caused by cardioembolism and 25.53% are of undetermined cause. We therefore encourage the use of transesophageal echocardiography in all patients with chagasic stroke. The appearance of apical aneurysm demands consideration of the institution of oral anticoagulation in such patients.
Although in the chronic chagasic form the appearance of LV dysfunction and apical aneurysm seem to represent a clear embolic source, it is not as clear why asymptomatic patients experience stroke. Prevalence of undetermined form of stroke seems to be similar in chagasic and nonchagasic stroke patients. However, we recognized the possibility that chagasic patients with no LV dysfunction might have experienced a stroke because of underlying systemic arterial hypertension. Some experimental works in the acute phase of experimental infection by T cruzi have showed aortic endothelial cell changes. 22 The relevance of endothelial dysfunction of the microcirculation as a potential cause of stroke in chagasic patients with no LV systolic dysfunction remains unknown.
In conclusion, apical aneurysm, cardiac insufficiency, and ECG arrhythmia seem to be important risk factors in the genesis of ischemic stroke related to CD, whereas hypercoagulable states are unlikely to be major contributors to the excess stroke risk seen in CD.
